Literature DB >> 16099550

Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis.

Roberto Del Bo1, Marina Scarlato, Serena Ghezzi, Filippo Martinelli-Boneschi, Chiara Fenoglio, Gloria Galimberti, Sara Galbiati, Roberta Virgilio, Daniela Galimberti, Carlo Ferrarese, Elio Scarpini, Nereo Bresolin, Giacomo Pietro Comi.   

Abstract

The methionine/valine (M/V) polymorphism at codon 129 within the prion protein gene (PRNP) represents a known risk factor for Creutzfeldt-Jakob disease (CJD). Few authors reported also the effects of this polymorphism on the risk of Alzheimer's disease (AD), although with controversial results. To better clarify this issue, we performed a novel case-control study and a meta-analysis of published association studies between PRNP and AD. Our findings argue against PRNP as a susceptibility gene for developing AD in the Italian population but support the hypothesis that the V allele influences cognitive performances. The meta-analysis, revealed that Caucasian subjects homozygous at codon 129 had a 1.3-fold increased risk [95% CI: 1.0-1.6, p = 0.05] of developing AD compared to heterozygous individuals. We also observed that MM genotype and M allele represent a risk factor for AD, independently from the ethnic background, providing a significant but modest association between this polymorphism and AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099550     DOI: 10.1016/j.neurobiolaging.2005.05.025

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

1.  Prion protein gene M129 allele is a risk factor for Alzheimer's disease.

Authors:  M Gacia; K Safranow; M Styczyńska; K Jakubowska; B Pepłońska; M Chodakowska-Zebrowska; I Przekop; A Słowik; E Golańska; K Hułas-Bigoszewska; D Chlubek; D Religa; C Zekanowski; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

2.  Regulation of amyloid-β production by the prion protein.

Authors:  Heledd H Griffiths; Isobel J Whitehouse; Nigel M Hooper
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 3.  Alzheimer's disease and prion protein.

Authors:  Jiayi Zhou; Bingqian Liu
Journal:  Intractable Rare Dis Res       Date:  2013-05

4.  Regional vulnerability in Alzheimer's disease: The role of cell-autonomous and transneuronal processes.

Authors:  Diana Acosta; Fontasha Powell; Yize Zhao; Ashish Raj
Journal:  Alzheimers Dement       Date:  2018-01-04       Impact factor: 21.566

5.  Unaltered prion protein expression in Alzheimer disease patients.

Authors:  Eri Saijo; Stephen W Scheff; Glenn C Telling
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

6.  PRND 3'UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease.

Authors:  Marcin Flirski; Monika Sieruta; Ewa Golańska; Iwona Kłoszewska; Paweł P Liberski; Tomasz Sobów
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

Review 7.  Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.

Authors:  Haakon B Nygaard; Stephen M Strittmatter
Journal:  Arch Neurol       Date:  2009-11

8.  ApoE distribution and family history in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Nicolas von Ahsen; Uta Heinemann; Bettina Meissner; Hans A Kretzschmar; Victor W Armstrong; Inga Zerr
Journal:  J Mol Neurosci       Date:  2007-09-11       Impact factor: 3.444

Review 9.  Prion protein and Alzheimer disease.

Authors:  Katherine A B Kellett; Nigel M Hooper
Journal:  Prion       Date:  2009-10-02       Impact factor: 3.931

Review 10.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.